Related Experiment Video
Updated: Aug 29, 2026

Recapitulating Suckling-to-Weaning Transition In Vitro using Fetal Intestinal Organoids
Published on: November 15, 2019
Acid secretion from birth to adulthood
1Children's Hospital of Greenville Hospital System, University of South Carolina School of Medicine, Greenville, South Carolina, USA. jboyle@ghs.org
Insights
Infants can maintain a low stomach pH from birth, similar to adults by 24 weeks. Further studies are needed to confirm the efficacy and safety of proton pump inhibitors (PPIs) in pediatric populations.
Area of Science:
- Neonatal Physiology
- Pediatric Gastroenterology
Background:
- Infants, including premature neonates (24 weeks gestational age), can maintain intragastric pH < 4 from birth.
- Maximal acid output in infants by 24 weeks approaches adult levels.
- Proton pump inhibitors (PPIs) are effective for reflux in adults.
Purpose of the Study:
- Evaluate the efficacy of proton pump inhibitors (PPIs) in infants and children.
- Determine appropriate PPI dosing for pediatric populations.
- Assess potential adverse events of long-term PPI use in children.
Main Methods:
- Further research is required to establish pediatric PPI efficacy.
- Clinical trials are needed to determine optimal pediatric dosing.
- Long-term safety studies are necessary for the pediatric population.
Main Results:
- Infant gastric acid production is significant early in life.
- Adult PPI efficacy suggests potential in pediatrics.
- Data on pediatric PPI use is currently lacking.
Conclusions:
- Pediatric studies are essential to validate PPI use.
- Appropriate dosing and safety profiles for infants and children require investigation.
- Potential side effects like hypergastrinemia and bacterial overgrowth need evaluation in pediatric PPI users.
Abstract:
All infants, including premature infants as young as 24 weeks' gestational age, are able to maintain an intragastric pH below 4 from the first day of life. By 24 weeks, maximal acid output approaches that in adults. In adult studies, proton pump inhibitors (PPIs) are highly effective in relieving reflux symptoms and healing reflux esophagitis. Studies are needed to evaluate PPI efficacy and appropriate dosing in infants and children. Consequences such as hypergastrinemia, bacterial overgrowth, and other potential adverse events associated with long-term PPI use also warrant evaluation in the pediatric population.
Related Concept Videos
Development of Human Microbiota
Development of the Oral Microbiota
Mucosal Barrier of the Stomach
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Accessory Structures of the Skin: Sebaceous Glands
These glands that produce the oils on the skin and hair are holocrine glands. The mature...
Stomach pH Regulation
The acid-secreting gastric mucosal epithelial cells (parietal cells) lining the stomach lumen maintain the low pH in the lumen. Numerous ion transporters and channels on these parietal...
Hormonal Regulation

